Literature DB >> 25859819

Identifying overlapping mutated driver pathways by constructing gene networks in cancer.

Hao Wu, Lin Gao, Feng Li, Fei Song, Xiaofei Yang, Nikola Kasabov.   

Abstract

BACKGROUND: Large-scale cancer genomic projects are providing lots of data on genomic, epigenomic and gene expression aberrations in many cancer types. One key challenge is to detect functional driver pathways and to filter out nonfunctional passenger genes in cancer genomics. Vandin et al. introduced the Maximum Weight Sub-matrix Problem to find driver pathways and showed that it is an NP-hard problem.
METHODS: To find a better solution and solve the problem more efficiently, we present a network-based method (NBM) to detect overlapping driver pathways automatically. This algorithm can directly find driver pathways or gene sets de novo from somatic mutation data utilizing two combinatorial properties, high coverage and high exclusivity, without any prior information. We firstly construct gene networks based on the approximate exclusivity between each pair of genes using somatic mutation data from many cancer patients. Secondly, we present a new greedy strategy to add or remove genes for obtaining overlapping gene sets with driver mutations according to the properties of high exclusivity and high coverage.
RESULTS: To assess the efficiency of the proposed NBM, we apply the method on simulated data and compare results obtained from the NBM, RME, Dendrix and Multi-Dendrix. NBM obtains optimal results in less than nine seconds on a conventional computer and the time complexity is much less than the three other methods. To further verify the performance of NBM, we apply the method to analyze somatic mutation data from five real biological data sets such as the mutation profiles of 90 glioblastoma tumor samples and 163 lung carcinoma samples. NBM detects groups of genes which overlap with known pathways, including P53, RB and RTK/RAS/PI(3)K signaling pathways. New gene sets with p-value less than 1e-3 are found from the somatic mutation data.
CONCLUSIONS: NBM can detect more biologically relevant gene sets. Results show that NBM outperforms other algorithms for detecting driver pathways or gene sets. Further research will be conducted with the use of novel machine learning techniques.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25859819      PMCID: PMC4402595          DOI: 10.1186/1471-2105-16-S5-S3

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  24 in total

1.  KEGG: kyoto encyclopedia of genes and genomes.

Authors:  M Kanehisa; S Goto
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.

Authors:  Christopher A Miller; Stephen H Settle; Erik P Sulman; Kenneth D Aldape; Aleksandar Milosavljevic
Journal:  BMC Med Genomics       Date:  2011-04-14       Impact factor: 3.063

3.  Efficient methods for identifying mutated driver pathways in cancer.

Authors:  Junfei Zhao; Shihua Zhang; Ling-Yun Wu; Xiang-Sun Zhang
Journal:  Bioinformatics       Date:  2012-09-14       Impact factor: 6.937

Review 4.  NeuCube: a spiking neural network architecture for mapping, learning and understanding of spatio-temporal brain data.

Authors:  Nikola K Kasabov
Journal:  Neural Netw       Date:  2014-01-20

5.  Epidermal growth factor receptor expression in neurofibromatosis type 1-related tumors and NF1 animal models.

Authors:  J E DeClue; S Heffelfinger; G Benvenuto; B Ling; S Li; W Rui; W C Vass; D Viskochil; N Ratner
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

6.  Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.

Authors:  Patricia Goldhoff; Jennifer Clarke; Ivan Smirnov; Mitchel S Berger; Michael D Prados; C David James; Arie Perry; Joanna J Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2012-01       Impact factor: 3.685

7.  Correlation of somatic mutation and expression identifies genes important in human glioblastoma progression and survival.

Authors:  David L Masica; Rachel Karchin
Journal:  Cancer Res       Date:  2011-05-09       Impact factor: 12.701

8.  STAR RNA-binding protein Quaking suppresses cancer via stabilization of specific miRNA.

Authors:  An-Jou Chen; Ji-Hye Paik; Hailei Zhang; Sachet A Shukla; Richard Mortensen; Jian Hu; Haoqiang Ying; Baoli Hu; Jessica Hurt; Natalie Farny; Caroline Dong; Yonghong Xiao; Y Alan Wang; Pamela A Silver; Lynda Chin; Shobha Vasudevan; Ronald A Depinho
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

9.  NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.

Authors:  Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo C Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
Journal:  PLoS Med       Date:  2007-02       Impact factor: 11.069

10.  Simultaneous identification of multiple driver pathways in cancer.

Authors:  Mark D M Leiserson; Dima Blokh; Roded Sharan; Benjamin J Raphael
Journal:  PLoS Comput Biol       Date:  2013-05-23       Impact factor: 4.475

View more
  8 in total

1.  DriveWays: a method for identifying possibly overlapping driver pathways in cancer.

Authors:  Ilyes Baali; Cesim Erten; Hilal Kazan
Journal:  Sci Rep       Date:  2020-12-15       Impact factor: 4.379

2.  Integrating Protein-Protein Interaction Networks and Somatic Mutation Data to Detect Driver Modules in Pan-Cancer.

Authors:  Hao Wu; Zhongli Chen; Yingfu Wu; Hongming Zhang; Quanzhong Liu
Journal:  Interdiscip Sci       Date:  2021-09-07       Impact factor: 2.233

3.  Identification of Gene Expression Pattern Related to Breast Cancer Survival Using Integrated TCGA Datasets and Genomic Tools.

Authors:  Zhenzhen Huang; Huilong Duan; Haomin Li
Journal:  Biomed Res Int       Date:  2015-10-20       Impact factor: 3.411

4.  An Effective Graph Clustering Method to Identify Cancer Driver Modules.

Authors:  Wei Zhang; Yifu Zeng; Lei Wang; Yue Liu; Yi-Nan Cheng
Journal:  Front Bioeng Biotechnol       Date:  2020-04-07

5.  Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns.

Authors:  Lidia Mateo; Miquel Duran-Frigola; Albert Gris-Oliver; Marta Palafox; Maurizio Scaltriti; Pedram Razavi; Sarat Chandarlapaty; Joaquin Arribas; Meritxell Bellet; Violeta Serra; Patrick Aloy
Journal:  Genome Med       Date:  2020-09-09       Impact factor: 11.117

6.  Identifying modules of cooperating cancer drivers.

Authors:  Michael I Klein; Vincent L Cannataro; Jeffrey P Townsend; Scott Newman; David F Stern; Hongyu Zhao
Journal:  Mol Syst Biol       Date:  2021-03       Impact factor: 11.429

7.  Prioritizing Cancer Genes Based on an Improved Random Walk Method.

Authors:  Pi-Jing Wei; Fang-Xiang Wu; Junfeng Xia; Yansen Su; Jing Wang; Chun-Hou Zheng
Journal:  Front Genet       Date:  2020-04-28       Impact factor: 4.599

8.  Network-based method for detecting dysregulated pathways in glioblastoma cancer.

Authors:  Hao Wu; Jihua Dong; Jicheng Wei
Journal:  IET Syst Biol       Date:  2018-02       Impact factor: 1.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.